Analysts expect over 2018 rising revenue Johnson & Johnson

Tomorrow Johnson & Johnson will publish its past quarter's results. Over the current book year the total revenue will be 81,47 billion USD (consensus estimates). This is slightly more than 2017's revenue of 76,45 billion USD.

Historical revenues and results Johnson & Johnson plus estimates 2018

The analysts expect for 2018 a net profit of 21,94 billion USD. For this year the consensus of Johnson & Johnson 's result per share is a profit of 8,12 USD. Based on this the price/earnings-ratio is 15,51.

For this year the analysts expect a dividend of 3,59 USD per share. Johnson & Johnson 's dividend yield thus equals 2,85 percent. The average dividend yield of the health care companies is a poor 1 percent.

Most recent target prices around 140 USD

The latest 3 recommendations for the health care company were provided by Jefferies & Co., KBC Securities and Sanford C. Bernstein & Co.

Based on the current number of outstanding shares Johnson & Johnson 's market capitalization is 340,83 billion USD.

On Friday the stock closed at 125,93 USD.

Price data Johnson & Johnson 2007-2018

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.